Your browser doesn't support javascript.
loading
Update on immunogenicity in severe asthma: Experience with mepolizumab.
Ortega, Hector G; Meyer, Erik; Brusselle, Guy; Asano, Koichiro; Prazma, Charlene M; Albers, Frank C; Mallett, Stephen A; Yancey, Steve W; Gleich, Gerald J.
Afiliação
  • Ortega HG; Respiratory US Medical Affairs, GSK, La Jolla, Calif. Electronic address: hortega@gossamerbio.com.
  • Meyer E; GSK, Philadelphia, Pa.
  • Brusselle G; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Asano K; Pulmonary Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Prazma CM; Respiratory Medical Franchise, GSK, Research Triangle Park, NC.
  • Albers FC; Respiratory Medical Franchise, GSK, Research Triangle Park, NC.
  • Mallett SA; Clinical Statistics, GSK, Stockley Park, Uxbridge, Middlesex, United Kingdom.
  • Yancey SW; Respiratory Medical Franchise, GSK, Research Triangle Park, NC.
  • Gleich GJ; School of Medicine, University of Utah, Utah.
J Allergy Clin Immunol Pract ; 7(7): 2469-2475.e1, 2019.
Article em En | MEDLINE | ID: mdl-30954640
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Hipersensibilidade a Drogas / Eosinófilos / Anticorpos Monoclonais Humanizados Limite: Adolescent / Adult / Child / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Hipersensibilidade a Drogas / Eosinófilos / Anticorpos Monoclonais Humanizados Limite: Adolescent / Adult / Child / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article